BioLife Historical Income Statement

BLFS Stock

USD 27.16 0.10 0.37%

Historical analysis of BioLife Solutions income statement accounts such as Selling General Administrative of 52.9 M, Total Revenue of 150.4 M or Gross Profit of 49.1 M can show how well BioLife Solutions performed in making a profits. Evaluating BioLife Solutions income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of BioLife Solutions's future profits or losses.

Cash Flow Balance Sheet Income Statement

Oil Shock

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining BioLife Solutions latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether BioLife Solutions is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioLife Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

For more information on how to buy BioLife Stock please use our How to Invest in BioLife Solutions guide.

About BioLife Income Statement Analysis

BioLife Solutions Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to BioLife Solutions shareholders. The income statement also shows BioLife investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

BioLife Solutions Income Statement Chart

At this time, BioLife Solutions' Total Other Income Expense Net is comparatively stable compared to the past year. Research Development is likely to gain to about 19.7 M in 2024, despite the fact that Operating Income is likely to grow to (67.3 M).

Selling General Administrative Total Revenue Other Operating Expenses Cost Of Revenue Net Income Income Before Tax

Total Revenue

Total revenue comprises all receipts BioLife Solutions generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of BioLife Solutions. It is also known as BioLife Solutions overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Cost Of Revenue

Cost of Revenue is found on BioLife Solutions income statement and represents the costs associated with goods and services BioLife Solutions provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in BioLife Solutions financial statement analysis. It represents the amount of money remaining after all of BioLife Solutions operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Income Before Tax

Income Before Tax which can also be referred as pre-tax income is reported on BioLife Solutions income statement and is an important metric when analyzing BioLife Solutions profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.

Most accounts from BioLife Solutions' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into BioLife Solutions current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioLife Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

For more information on how to buy BioLife Stock please use our How to Invest in BioLife Solutions guide.At this time, BioLife Solutions' Total Other Income Expense Net is comparatively stable compared to the past year. Research Development is likely to gain to about 19.7 M in 2024, despite the fact that Operating Income is likely to grow to (67.3 M).

	2021	2022	2023	2024 (projected)
Total Operating Expenses	68.1M	93.7M	117.6M	123.5M
Cost Of Revenue	81.4M	107.9M	96.5M	101.3M

Total Operating Expenses Cost Of Revenue

BioLife Solutions income statement Correlations

	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Net Income	Income Tax Expense	Depreciation And Amortization	Income Before Tax	Total Other Income Expense Net	Research Development	Selling And Marketing Expenses	Net Income From Continuing Ops	Non Operating Income Net Other	Minority Interest	Interest Income	Net Interest Income	Reconciled Depreciation	Tax Provision	Non Recurring
Interest Expense		0.76	0.69	0.61	0.76	-0.86	-0.82	-0.88	0.72	0.79	-0.58	0.03	0.56	-0.56	0.23	0.75	-0.15	-0.71	0.64	-0.03	-0.21	-0.88	0.56	0.12	-0.62
Selling General Administrative	0.76		0.99	0.96	1.0	-0.97	-0.99	-0.95	0.98	1.0	-0.81	-0.35	0.93	-0.83	0.4	0.99	-0.12	-0.89	0.85	-0.51	-0.02	-0.73	0.92	-0.22	-0.92
Total Revenue	0.69	0.99		0.98	0.99	-0.92	-0.96	-0.89	1.0	0.98	-0.83	-0.45	0.97	-0.86	0.38	0.97	-0.11	-0.88	0.86	-0.53	0.0	-0.64	0.94	-0.33	-0.92
Gross Profit	0.61	0.96	0.98		0.96	-0.87	-0.91	-0.83	0.96	0.95	-0.78	-0.43	0.95	-0.82	0.49	0.95	-0.16	-0.84	0.84	-0.63	0.12	-0.53	0.93	-0.3	-0.93
Other Operating Expenses	0.76	1.0	0.99	0.96		-0.96	-0.99	-0.94	0.99	0.99	-0.81	-0.38	0.94	-0.84	0.38	0.99	-0.1	-0.89	0.85	-0.49	-0.04	-0.72	0.92	-0.26	-0.91
Operating Income	-0.86	-0.97	-0.92	-0.87	-0.96		0.99	1.0	-0.93	-0.98	0.75	0.22	-0.82	0.76	-0.34	-0.96	0.06	0.86	-0.79	0.39	0.12	0.86	-0.82	0.1	0.84
Ebit	-0.82	-0.99	-0.96	-0.91	-0.99	0.99		0.98	-0.97	-0.99	0.8	0.32	-0.89	0.82	-0.33	-0.97	0.07	0.89	-0.83	0.41	0.12	0.82	-0.88	0.2	0.88
Ebitda	-0.88	-0.95	-0.89	-0.83	-0.94	1.0	0.98		-0.91	-0.96	0.73	0.18	-0.79	0.74	-0.32	-0.94	0.05	0.85	-0.77	0.34	0.15	0.89	-0.78	0.07	0.81
Cost Of Revenue	0.72	0.98	1.0	0.96	0.99	-0.93	-0.97	-0.91		0.97	-0.83	-0.45	0.97	-0.87	0.33	0.97	-0.09	-0.88	0.85	-0.48	-0.06	-0.69	0.93	-0.34	-0.91
Total Operating Expenses	0.79	1.0	0.98	0.95	0.99	-0.98	-0.99	-0.96	0.97		-0.79	-0.31	0.9	-0.81	0.42	0.99	-0.11	-0.88	0.84	-0.5	-0.02	-0.75	0.89	-0.18	-0.91
Net Income	-0.58	-0.81	-0.83	-0.78	-0.81	0.75	0.8	0.73	-0.83	-0.79		0.1	-0.83	0.99	-0.09	-0.76	0.04	0.97	-0.64	0.31	0.16	0.61	-0.88	0.01	0.66
Income Tax Expense	0.03	-0.35	-0.45	-0.43	-0.38	0.22	0.32	0.18	-0.45	-0.31	0.1		-0.58	0.23	-0.13	-0.34	0.07	0.05	-0.46	0.29	-0.02	-0.06	-0.42	0.98	0.47
Depreciation And Amortization	0.56	0.93	0.97	0.95	0.94	-0.82	-0.89	-0.79	0.97	0.9	-0.83	-0.58		-0.88	0.31	0.9	-0.1	-0.83	0.85	-0.51	-0.05	-0.53	0.96	-0.47	-0.9
Income Before Tax	-0.56	-0.83	-0.86	-0.82	-0.84	0.76	0.82	0.74	-0.87	-0.81	0.99	0.23	-0.88		-0.09	-0.78	0.05	0.96	-0.68	0.35	0.16	0.59	-0.91	0.14	0.71
Total Other Income Expense Net	0.23	0.4	0.38	0.49	0.38	-0.34	-0.33	-0.32	0.33	0.42	-0.09	-0.13	0.31	-0.09		0.46	-0.06	-0.23	0.3	-0.34	0.68	0.01	0.33	0.03	-0.42
Research Development	0.75	0.99	0.97	0.95	0.99	-0.96	-0.97	-0.94	0.97	0.99	-0.76	-0.34	0.9	-0.78	0.46		-0.01	-0.85	0.85	-0.5	-0.01	-0.72	0.88	-0.21	-0.93
Selling And Marketing Expenses	-0.15	-0.12	-0.11	-0.16	-0.1	0.06	0.07	0.05	-0.09	-0.11	0.04	0.07	-0.1	0.05	-0.06	-0.01		0.04	-0.03	0.32	-0.12	-0.05	-0.08	0.06	0.09
Net Income From Continuing Ops	-0.71	-0.89	-0.88	-0.84	-0.89	0.86	0.89	0.85	-0.88	-0.88	0.97	0.05	-0.83	0.96	-0.23	-0.85	0.04		-0.68	0.35	0.1	0.72	-0.88	-0.06	0.72
Non Operating Income Net Other	0.64	0.85	0.86	0.84	0.85	-0.79	-0.83	-0.77	0.85	0.84	-0.64	-0.46	0.85	-0.68	0.3	0.85	-0.03	-0.68		-0.29	-0.26	-0.62	0.81	-0.34	-0.95
Minority Interest	-0.03	-0.51	-0.53	-0.63	-0.49	0.39	0.41	0.34	-0.48	-0.5	0.31	0.29	-0.51	0.35	-0.34	-0.5	0.32	0.35	-0.29		-0.36	0.03	-0.47	0.24	0.51
Interest Income	-0.21	-0.02	0.0	0.12	-0.04	0.12	0.12	0.15	-0.06	-0.02	0.16	-0.02	-0.05	0.16	0.68	-0.01	-0.12	0.1	-0.26	-0.36		0.5	-0.04	0.05	0.11
Net Interest Income	-0.88	-0.73	-0.64	-0.53	-0.72	0.86	0.82	0.89	-0.69	-0.75	0.61	-0.06	-0.53	0.59	0.01	-0.72	-0.05	0.72	-0.62	0.03	0.5		-0.55	-0.12	0.59
Reconciled Depreciation	0.56	0.92	0.94	0.93	0.92	-0.82	-0.88	-0.78	0.93	0.89	-0.88	-0.42	0.96	-0.91	0.33	0.88	-0.08	-0.88	0.81	-0.47	-0.04	-0.55		-0.3	-0.89
Tax Provision	0.12	-0.22	-0.33	-0.3	-0.26	0.1	0.2	0.07	-0.34	-0.18	0.01	0.98	-0.47	0.14	0.03	-0.21	0.06	-0.06	-0.34	0.24	0.05	-0.12	-0.3		0.35
Non Recurring	-0.62	-0.92	-0.92	-0.93	-0.91	0.84	0.88	0.81	-0.91	-0.91	0.66	0.47	-0.9	0.71	-0.42	-0.93	0.09	0.72	-0.95	0.51	0.11	0.59	-0.89	0.35

Click cells to compare fundamentals

BioLife Solutions Account Relationship Matchups

BioLife Solutions income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Selling General Administrative	9.1M	14.6M	34.1M	47.7M	55.7M	52.9M
Total Revenue	27.4M	48.1M	119.2M	161.8M	143.3M	150.4M
Gross Profit	18.5M	27.4M	37.7M	53.8M	46.8M	49.1M
Other Operating Expenses	27.0M	51.4M	149.5M	201.7M	214.1M	224.8M
Operating Income	(781K)	(3.3M)	(30.4M)	(39.9M)	(70.8M)	(67.3M)
Ebit	(781K)	(4.7M)	(32.7M)	(43.1M)	(57.5M)	(54.7M)
Ebitda	1.0M	1.1M	(17.8M)	(23.2M)	(45.2M)	(43.0M)
Cost Of Revenue	8.9M	20.6M	81.4M	107.9M	96.5M	101.3M
Total Operating Expenses	18.2M	30.8M	68.1M	93.7M	117.6M	123.5M
Net Income	11.1M	2.7M	(8.4M)	(139.8M)	(66.4M)	(63.1M)
Income Tax Expense	(1.5M)	(3.3M)	(20.3M)	(5.0M)	169K	177.5K
Depreciation And Amortization	1.8M	5.8M	14.9M	20.0M	12.3M	12.9M
Income Before Tax	9.5M	(597K)	(28.7M)	(144.8M)	(66.3M)	(62.9M)
Total Other Income Expense Net	10.3M	5.0M	1.3M	714K	4.6M	4.8M
Research Development	4.1M	6.7M	11.8M	14.8M	18.8M	19.7M
Selling And Marketing Expenses	5.0M	6.4M	14.0M	21.6M	24.6M	23.4M
Net Income From Continuing Ops	(1.7M)	2.7M	(8.4M)	(139.8M)	(102.2M)	(97.1M)
Non Operating Income Net Other	(1.3M)	(391K)	(3.0M)	5.0M	5.7M	6.0M
Net Income Applicable To Common Shares	(1.7M)	2.7M	(8.4M)	(139.8M)	(125.8M)	(119.5M)
Interest Income	350.0	281K	506K	58K	66.7K	63.4K
Net Interest Income	501K	58K	(432K)	(687K)	(1.7M)	(1.7M)
Reconciled Depreciation	1.8M	5.1M	8.2M	16.5M	13.1M	7.1M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for BioLife Stock Analysis

When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

BioLife Historical Income Statement

About BioLife Income Statement Analysis

BioLife Solutions Income Statement Chart

Total Revenue

Other Operating Expenses

Cost Of Revenue

Net Income

Income Before Tax

BioLife Solutions income statement Correlations

BioLife Solutions Account Relationship Matchups

High Positive Relationship

High Negative Relationship

BioLife Solutions income statement Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for BioLife Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Other Operating Expenses	+ 1.0	Selling General Administrative
Total Operating Expenses	+ 1.0	Selling General Administrative
Cost Of Revenue	+ 1.0	Total Revenue
Ebitda	+ 1.0	Operating Income
Total Revenue	+ 0.99	Selling General Administrative
Research Development	+ 0.99	Selling General Administrative

Total Operating Expenses	- 0.99	Ebit
Ebit	- 0.99	Other Operating Expenses
Ebit	- 0.99	Selling General Administrative
Total Operating Expenses	- 0.98	Operating Income
Research Development	- 0.97	Ebit
Cost Of Revenue	- 0.97	Ebit